These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 1377893

  • 1. C-erbB-2 expression in squamous cell carcinoma of the head and neck.
    Field JK, Spandidos DA, Yiagnisis M, Gosney JR, Papadimitriou K, Stell PM.
    Anticancer Res; 1992; 12(3):613-9. PubMed ID: 1377893
    [Abstract] [Full Text] [Related]

  • 2. Expression of c-erbB-2 gene in human head and neck carcinoma.
    Craven JM, Pavelic ZP, Stambrook PJ, Pavelic L, Gapany M, Kelley DJ, Gapany S, Gluckman JL.
    Anticancer Res; 1992; 12(6B):2273-6. PubMed ID: 1363518
    [Abstract] [Full Text] [Related]

  • 3. Expression of c-erbB proto-oncogene family members in squamous cell carcinoma of the head and neck.
    Ibrahim SO, Vasstrand EN, Liavaag PG, Johannessen AC, Lillehaug JR.
    Anticancer Res; 1997; 17(6D):4539-46. PubMed ID: 9494565
    [Abstract] [Full Text] [Related]

  • 4. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
    Giatromanolaki A, Koukourakis MI, Sivridis E, Fountzilas G.
    Anticancer Res; 2000; 20(2A):997-1004. PubMed ID: 10810387
    [Abstract] [Full Text] [Related]

  • 5. Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma.
    Field JK, Spandidos DA, Stell PM, Vaughan ED, Evan GI, Moore JP.
    Oncogene; 1989 Dec; 4(12):1463-8. PubMed ID: 2687767
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
    McCann AH, Dervan PA, O'Regan M, Codd MB, Gullick WJ, Tobin BM, Carney DN.
    Cancer Res; 1991 Jun 15; 51(12):3296-303. PubMed ID: 1674898
    [Abstract] [Full Text] [Related]

  • 7. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
    Lipponen HJ, Aaltomaa S, Syrjänen S, Syrjänen K.
    Anticancer Res; 1993 Jun 15; 13(4):1147-52. PubMed ID: 8102517
    [Abstract] [Full Text] [Related]

  • 8. Squamous cell carcinomas, an immunohistochemical and ultrastructural study.
    Suo Z, Holm R, Nesland JM.
    Anticancer Res; 1992 Jun 15; 12(6B):2025-31. PubMed ID: 1284199
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical study of c-fos-positive lymphocytes infiltrated into human squamous cell carcinomas of the head and neck during radiation therapy and its clinical significance.
    Ogawa Y, Nishioka A, Hamada N, Terashima M, Inomata T, Yoshida S, Seguchi H, Kishimoto S.
    Clin Cancer Res; 1997 Dec 15; 3(12 Pt 1):2301-7. PubMed ID: 9815628
    [Abstract] [Full Text] [Related]

  • 10. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M.
    J Urol; 2001 May 15; 165(5):1481-7. PubMed ID: 11342901
    [Abstract] [Full Text] [Related]

  • 11. C-erbB-2 protein and neuroendocrine expression in breast carcinomas.
    Nesland JM, Ottestad L, Heikilla R, Holm R, Tveit K, Børresen AL.
    Anticancer Res; 1991 May 15; 11(1):161-7. PubMed ID: 1673329
    [Abstract] [Full Text] [Related]

  • 12. Expression of c-erbB-2 oncoprotein in salivary gland tumours: an immunohistochemical study.
    Kernohan NM, Blessing K, King G, Corbett IP, Miller ID.
    J Pathol; 1991 Jan 15; 163(1):77-80. PubMed ID: 1672154
    [Abstract] [Full Text] [Related]

  • 13. Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma.
    Xia W, Lau YK, Zhang HZ, Liu AR, Li L, Kiyokawa N, Clayman GL, Katz RL, Hung MC.
    Clin Cancer Res; 1997 Jan 15; 3(1):3-9. PubMed ID: 9815530
    [Abstract] [Full Text] [Related]

  • 14. High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas.
    Yi ES, Harclerode D, Gondo M, Stephenson M, Brown RW, Younes M, Cagle PT.
    Mod Pathol; 1997 Feb 15; 10(2):142-8. PubMed ID: 9127320
    [Abstract] [Full Text] [Related]

  • 15. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
    Ai L, Stephenson KK, Ling W, Zuo C, Mukunyadzi P, Suen JY, Hanna E, Fan CY.
    Mod Pathol; 2003 Sep 15; 16(9):944-50. PubMed ID: 13679459
    [Abstract] [Full Text] [Related]

  • 16. Improved immunohistochemical detection of p53 protein in paraffin--embedded tissues reveals elevated levels in most head and neck and lung carcinomas: correlation with clinicopathological parameters.
    Pavelic ZP, Gluckman JL, Gapany M, Reising J, Craven JM, Kelley DJ, Pavelic L, Gapany S, Biddinger P, Stambrook PJ.
    Anticancer Res; 1992 Sep 15; 12(5):1389-94. PubMed ID: 1444195
    [Abstract] [Full Text] [Related]

  • 17. Amplification of the int-2 gene in human head and neck squamous cell carcinomas.
    Somers KD, Cartwright SL, Schechter GL.
    Oncogene; 1990 Jun 15; 5(6):915-20. PubMed ID: 2193294
    [Abstract] [Full Text] [Related]

  • 18. Significance of immunohistochemically detected c-erbB-2 protein expression in stage III breast cancer, with reference to nuclear deformity, DNA content and prognosis.
    Tamura G, Maesawa C, Mikawa S, Satodate R.
    Jpn J Clin Oncol; 1991 Aug 15; 21(4):264-7. PubMed ID: 1682519
    [Abstract] [Full Text] [Related]

  • 19. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
    Mandai M, Konishi I, Koshiyama M, Mori T, Arao S, Tashiro H, Okamura H, Nomura H, Hiai H, Fukumoto M.
    Cancer Res; 1994 Apr 01; 54(7):1825-30. PubMed ID: 7907945
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of c-myc and p53 expression in head and neck squamous cell carcinomas.
    Waitzberg AF, Nonogaki S, Nishimoto IN, Kowalski LP, Miguel RE, Brentani RR, Brentani MM.
    Cancer Detect Prev; 2004 Apr 01; 28(3):178-86. PubMed ID: 15225897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.